COVID-19 Webinars

COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices

By May 7, 2020April 22nd, 2021No Comments

JDD Multimedia

COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices

Join your dermatology colleagues and thought leaders as we examine the hidden impact of COVID-19 on dermatologists and providers, including new and small private practices, emotional wellbeing and the evolving priorities placed on providers during the global coronavirus pandemic. Panelists will discuss their first-hand, personal experience living with COVID-19 and ways it has impacted their physical and emotional health, practice and personal life.
Discussion and guidance will be given on simple steps you can take in the wellness sphere, crisis management and return to practice concepts for both large and small dermatology practices.

Moderators

  • Richard G. Fried, MD, PhD (Board Certified Dermatologist & Clinical Psychologist, Clinical Director, Yardley Dermatology Associates)

Panelists

  • Evan Rieder, MD (Board Certified Dermatologist & Psychiatrist, NYU Langone Health)
  • Paul Jarrod Frank, MD (Chief Medical Officer & Founder, PFRANKMD)
  • Melissa Kanchanapoomi Levin, MD (Founder, Entière Dermatology)

You May Also Like

Featured ArticlesLatest News
February 17, 2026

Dermatology Roundup: Concomitant Use of Taltz and Zepbound

Lilly published the results of a Phase 3b clinical trial that showed treatment with concomitant Taltz (ixekizumab) and Zepbound (tirzepatide) was superior to ixekizumab alone in patients with active psoriatic…
Journal of Drugs in Dermatology JDD Article about Excimer Laser for Plaque Psoriasis: A Systematic Review and Meta-analysisFeatured ArticlesLasers & Light DevicesLatest NewsPsoriasis
February 16, 2026

Excimer Laser for Plaque Psoriasis: A Systematic Review and Meta-analysis

In this article from JDD: Excimer laser delivers measurable PASI gains but evidence is limited A JDD  meta‑analysis of 308 nm excimer laser treatment for plaque psoriasis pooled four clinical…
Featured ArticlesLatest NewsMedical Derm
February 16, 2026

Pentoxifylline as a Steroid-Sparing Agent in Granuloma Annulare: A Rural Retrospective Study

A JDD retrospective review links generalized disease to higher comorbidity burden and reports favorable response to pentoxifylline In this article from JDD’s February 2026’s issue, authors present a single center,…

Leave a Reply